These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2799279)

  • 61. Revised recommendation (1983) on evaluation of diagnostic kits. Part 2. Guidelines for the evaluation of clinical chemistry kits.
    Logan JE
    J Clin Chem Clin Biochem; 1983 Dec; 21(12):899-902. PubMed ID: 6663250
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increasing the biosafety of analytical systems in the clinical laboratory. International Federation of Clinical Chemistry (IFCC).
    Truchaud A; Schnipelsky P; Pardue HL; Place J; Ozawa K
    Ann Biol Clin (Paris); 1994; 52(5):393-6. PubMed ID: 7856943
    [No Abstract]   [Full Text] [Related]  

  • 63. Data base management systems for evaluation of analytical procedures.
    Groth T; Larsson O; Aronsson T; de Verdier CH
    Scand J Clin Lab Invest Suppl; 1984; 172():209-13. PubMed ID: 6599525
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reference materials and methods in clinical chemistry. Report of a Discussion Group Meeting held on the occasion of the 1st European Congress of Clinical Chemistry. Munich, 23rd April 1974.
    Rinsler MG; Mitchell FL
    Z Klin Chem Klin Biochem; 1974 Dec; 12(12):558-74. PubMed ID: 4156105
    [No Abstract]   [Full Text] [Related]  

  • 65. [Quality control for trace elements in occupational and environmental medicine].
    Morisi G; Patriarca M; Menditto A
    Ann Ist Super Sanita; 1995; 31(2):245-54. PubMed ID: 8561388
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Observations on the specifics in the quality of drugs].
    Setnikar I
    Boll Chim Farm; 1968 Mar; 107(3):158-67. PubMed ID: 5730323
    [No Abstract]   [Full Text] [Related]  

  • 67. Are single-dose toxicology studies in animals adequate to support single doses of a new drug in humans?
    Monro A; Mehta D
    Clin Pharmacol Ther; 1996 Mar; 59(3):258-64. PubMed ID: 8653987
    [No Abstract]   [Full Text] [Related]  

  • 68. [Carcinogens in pharmacy and in the laboratory of analytical chemistry].
    Reith JF
    Pharm Weekbl; 1972 Sep; 107(37):581-97. PubMed ID: 4653228
    [No Abstract]   [Full Text] [Related]  

  • 69. Quality of dry chemistry testing.
    Nakamura H; Tatsumi N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():130-5. PubMed ID: 10926273
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The challenge of in-hospital medication use: an opportunity for clinical pharmacology.
    Atkinson AJ; Nordstrom K
    Clin Pharmacol Ther; 1996 Oct; 60(4):363-7. PubMed ID: 8873683
    [No Abstract]   [Full Text] [Related]  

  • 71. [Solution of pharmacological problems by computers. 7. An ALGOL-program for the Hückel method (HMO method) for the quantititive chemical determination of molecular states].
    Krüger-Thiemer E; Hansen R
    Arzneimittelforschung; 1966 Nov; 16(11):1453-66. PubMed ID: 6015009
    [No Abstract]   [Full Text] [Related]  

  • 72. [Effects of drugs on analytic results in clinical chemistry].
    Tryding N; Ericson C; Roos KA
    Lakartidningen; 1987 Jul; 84(30-31):2416-8. PubMed ID: 3626707
    [No Abstract]   [Full Text] [Related]  

  • 73. Basic safety pharmacology: the cardiovascular system.
    Lacroix P; Provost D
    Therapie; 2000; 55(1):63-9. PubMed ID: 10860003
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Near infrared reflectance analysis: features and applications in pharmaceutical and biomedical analysis.
    Corti P; Dreassi E; Leonardi S
    Farmaco; 1993 Jan; 48(1):3-20. PubMed ID: 8457277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PAT Program report: background and current status. Proficiency Analytical Testing.
    Grunder FI; Bell C
    AIHAJ; 2000; 61(6):900-1. PubMed ID: 11192226
    [No Abstract]   [Full Text] [Related]  

  • 76. Drug effects in clinical chemistry. Part 2. Guidelines for evaluation of analytical interference.
    Galteau MM; Siest G
    J Clin Chem Clin Biochem; 1984 Mar; 22(3):275-9. PubMed ID: 6726127
    [No Abstract]   [Full Text] [Related]  

  • 77. Biopharmaceutical Emerging Best Practices Association 2009.
    Robinson CJ
    Bioanalysis; 2010 Jan; 2(1):43-5. PubMed ID: 21083117
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessing (analytical) quality in clinical chemistry. Review of pertinent literature.
    Hørder M
    Scand J Clin Lab Invest Suppl; 1980; 155():7-10. PubMed ID: 7034149
    [No Abstract]   [Full Text] [Related]  

  • 79. Analytical goals for interference.
    Fuentes-Arderiu X; Fraser CG
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():393-5. PubMed ID: 1892351
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synopsis of methods for obtaining quality requirements in clinical chemistry.
    Solberg HE
    Scand J Clin Lab Invest Suppl; 1980; 155():29-30. PubMed ID: 6948365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.